Don't Miss

Trends and Innovations in Patient Adherence presents the candid insights of 16 leading experts from the pharma industry, health payers and patient advocacy groups in the US and Europe.

All agree that good patient adherence to their treatment regime is critical. However, a number of patients decide not to take their medicines as directed. The direct and consequential cost and health impacts of poor patient adherence are considerable, but changing behaviour is proving a challenge. For deep background research and critical insights to tackle this issue turn to this new report. Learn more.

AbbVie's all-oral, interferon-free therapy for Hepatitis C receives FDA priority review